1. Home
  2. ENTX vs ARAI Comparison

ENTX vs ARAI Comparison

Compare ENTX & ARAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Entera Bio Ltd.

ENTX

Entera Bio Ltd.

HOLD

Current Price

$2.37

Market Cap

142.0M

Sector

Health Care

ML Signal

HOLD

ARAI

Arrive AI Inc. Common Stock

N/A

Current Price

$3.70

Market Cap

143.7M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ENTX
ARAI
Founded
2010
2020
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Diversified Commercial Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
142.0M
143.7M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ENTX
ARAI
Price
$2.37
$3.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$10.00
$12.00
AVG Volume (30 Days)
107.9K
116.6K
Earning Date
11-14-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$124,000.00
$98,175.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
25.25
N/A
52 Week Low
$1.50
$3.03
52 Week High
$3.22
$40.00

Technical Indicators

Market Signals
Indicator
ENTX
ARAI
Relative Strength Index (RSI) 39.09 N/A
Support Level $2.26 N/A
Resistance Level $2.53 N/A
Average True Range (ATR) 0.23 0.00
MACD -0.07 0.00
Stochastic Oscillator 6.05 0.00

Price Performance

Historical Comparison
ENTX
ARAI

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

About ARAI Arrive AI Inc. Common Stock

Arrive AI Inc is a technology company. Its patented Autonomous Last Mile (ALM) platform enables secure, efficient delivery to and from a smart, AI-powered mailbox-whether by drone, ground robot, or human courier. The platform provides real-time tracking, smart logistics alerts, and advanced chain-of-custody controls to support shippers, delivery services, and autonomous networks. By combining artificial intelligence with autonomous technology, Arrive AI makes the exchange of goods between people, robots, and drones frictionless and convenient. Its system integrates with smart home devices such as doorbells, lighting, and security systems to streamline the entire last-mile delivery experience.

Share on Social Networks: